For the Inventor, By the Inventor

Enter inventor name

Mario Varasi

USPTO Granted Patents = 72 (Patent Applications = 3)

CIPO Patents = 7 (Patent Applications = 3)

EPO Patents = 14 (Patent Applications = 18)

Average Co-Inventor Count = 5.0

ph-index = 17

Forward Citations = 823(Granted Patents)

Forward Citations (Not Self Cited) = 793(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Milano, IT (2009)
Milan, IT (1992 - 2021)

Company Filing History:

Pharmacia & Upjohn S.p.a.

Farmitalia Carlo Erba S.r.l.

Pfizer Italia S.r.l.

4. 7 out of 138

Nerviano Medical Sciences S.r.l.

Istituto Europeo Di Oncologia S.r.l.

Pharmacia Italia S.p.a.

Newron Pharmaceuticals S.p.a.

8. 3 out of 1,929

University System of Maryland

10. 2 out of 20

Pharmacia S.p.a.

11. 1 out of 523

Pharmacia & Upjohn Company

Pharmacia & Tubjohn Spa

Ifom Fondazione Istituto Firc Di Oncologia Molecolare

Ieo - Istituto Europeo Di Oncologia S.r.l.

17. 2 out of 832,843

Other

patents

where one patent can have more than one assignee

Years Active: 1992-2025

Loading Chart...

Loading Chart...

Loading Chart...

Areas of Expertise:

HECT E3 Ligase Inhibitors

Histone Demethylase Inhibitors

Cyclopropylamine Compounds

Spirocyclic Derivatives

Kinase Inhibitors

Antitumor Agents

Integrin Receptor Antagonists

Amino Benzothiazole Derivatives

Azaindole Derivatives

Phenylacetamido-Pyrazole Derivatives

Neurodegenerative Ergoline Derivatives

Kynurenine-3-Hydroxylase Inhibitors

72 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12403144 - HECT E3 ligase inhibitors and uses thereof (2025-09-02),

2. 10980777 - Indole derivatives as histone demethylase inhibitors (2021-04-20),

3. 10961255 - Imidazoles as histone demethylase inhibitors (2021-03-30),

4. 10562914 - Imidazoles as histone demethylase inhibitors (2020-02-18),

5. 10233165 - Cyclopropylamine compounds as histone demethylase inhibitors (2019-03-19),

6. 10183952 - Thienopyrroles as histone demethylase inhibitors (2019-01-22),

7. 9944589 - Cycloproplyamine derivatives useful as inhibitors of histone demethylases KDM1A (2018-04-17),

8. 9701686 - Tricyclopyrazole derivatives (2017-07-11),

9. 9127015 - Tricyclopyrazole derivatives (2015-09-08),

10. 9115148 - Spirocyclic derivatives as histone deacetylase inhibitors (2015-08-25),

11. 8980877 - Spirocyclic derivatives as histone deacetylase inhibitors (2015-03-17),

12. 8669261 - Acrylomido derivatives useful as inhibitors of the mitochondrial permeability transition (2014-03-11),

13. 8592444 - Spirocyclic derivatives as histone deacetylase inhibitors (2013-11-26),

14. 8481584 - 1H-thieno[2,3-c]pyrazole derivatives useful as kinase inhibitors (2013-07-09),

15. 8470831 - Acrylamido derivatives useful as inhibitors of the mitochondrial permeability transition (2013-06-25),

Title: The Innovative Mind of Mario Varasi

Introduction: Mario Varasi, a distinguished inventor hailing from Milan, Italy, is renowned for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Mario Varasi's latest patents include cutting-edge advancements in artificial intelligence, renewable energy technologies, and sustainable urban development solutions.

Career Highlights: With a career spanning over two decades, Mario Varasi has consistently pushed the boundaries of technological innovation. His work has revolutionized various industries, earning him recognition as a visionary in the field.

Collaborations: Mario Varasi has collaborated with leading research institutions, universities, and multinational companies to bring his innovative ideas to life. His partnerships have resulted in the development of groundbreaking technologies that have had a lasting impact on society.

Conclusion: Mario Varasi's relentless pursuit of innovation and his passion for creating a better future through technology make him a true pioneer in the world of inventions. His contributions continue to inspire the next generation of inventors and shape the landscape of technological advancements.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…